D'Alessandro Angelo, Culp-Hill Rachel, Reisz Julie A, Anderson Mikayla, Fu Xiaoyun, Nemkov Travis, Gehrke Sarah, Zheng Connie, Kanias Tamir, Guo Yuelong, Page Grier, Gladwin Mark T, Kleinman Steve, Lanteri Marion, Stone Mars, Busch Michael, Zimring James C
Department of Biochemistry and Molecular Genetics, University of Colorado Denver-Anschutz Medical Campus, Aurora, Colorado.
BloodWorks Northwest, Seattle, Washington.
Transfusion. 2019 Jan;59(1):89-100. doi: 10.1111/trf.14979. Epub 2018 Oct 24.
Biological and technical variability has been increasingly appreciated as a key factor impacting red blood cell (RBC) storability and, potentially, transfusion outcomes. Here, we performed metabolomics analyses to investigate the impact of factors other than storage duration on the metabolic phenotypes of stored RBC in a multicenter study.
Within the framework of the REDS-III (Recipient Epidemiology and Donor Evaluation Study-III) RBC-Omics study, 13,403 donors were enrolled from four blood centers across the United States and tested for the propensity of their RBCs to hemolyze after 42 days of storage. Extreme hemolyzers were recalled and donated a second unit of blood. Units were stored for 10, 23, and 42 days prior to sample acquisition for metabolomics analyses.
Unsupervised analyses of metabolomics data from 599 selected samples revealed a strong impact (14.2% of variance) of storage duration on metabolic phenotypes of RBCs. The blood center collecting and processing the units explained an additional 12.2% of the total variance, a difference primarily attributable to the storage additive (additive solution 1 vs. additive solution 3) used in the different hubs. Samples stored in mannitol-free/citrate-loaded AS-3 were characterized by elevated levels of high-energy compounds, improved glycolysis, and glutathione homeostasis. Increased methionine metabolism and activation of the transsulfuration pathway was noted in samples processed in the center using additive solution 1.
Blood processing impacts the metabolic heterogeneity of stored RBCs from the largest multicenter metabolomics study in transfusion medicine to date. Studies are needed to understand if these metabolic differences influenced by processing/storage strategies impact the effectiveness of transfusions clinically.
生物和技术变异性日益被视为影响红细胞(RBC)储存能力以及潜在输血结果的关键因素。在此,我们进行了代谢组学分析,以在一项多中心研究中探究储存持续时间以外的因素对储存RBC代谢表型的影响。
在REDS-III(受者流行病学和供者评估研究III)RBC-组学研究框架内,从美国四个血液中心招募了13403名供者,并检测其RBC在储存42天后溶血的倾向。召回溶血倾向高的供者并让其再次捐献一份血液。在采集样本进行代谢组学分析之前,将血液单位分别储存10天、23天和42天。
对599个选定样本的代谢组学数据进行无监督分析发现,储存持续时间对RBC代谢表型有强烈影响(占方差的14.2%)。收集和处理血液单位的血液中心又解释了总方差的12.2%,这种差异主要归因于不同中心使用的储存添加剂(添加剂溶液1与添加剂溶液3)。储存在不含甘露醇/富含柠檬酸盐的AS-3中的样本具有高能化合物水平升高、糖酵解改善和谷胱甘肽稳态的特征。在使用添加剂溶液1处理的中心的样本中,观察到蛋氨酸代谢增加和转硫途径的激活。
在迄今为止输血医学领域最大规模的多中心代谢组学研究中,血液处理会影响储存RBC的代谢异质性。需要开展研究以了解这些受处理/储存策略影响的代谢差异是否会在临床上影响输血效果。